Transcatheter aortic valve implantation (TAVI) has proven to be a viable alternative for patients with symptomatic severe aortic stenosis who are at high risk for surgical aortic valve replacement. At the same time, there is increasing evidence that moderateto-severe periprosthetic aortic regurgitation after TAVI is associated with dramatically increased mortality and morbidity. The issue of pr...

Significant mitral valve regurgitation creates progressive adverse remodeling of the left ventricle (LV). Replacement failing with a prosthesis generally improves patient outcomes but leaves non-physiological intracardiac flow patterns that might contribute to their future risk thrombus formation and embolism. It has been suggested angular orientation implanted modify postoperative distortion i...

An 84-year-old man underwent transcatheter aortic valve implantation (TAVI) for severe, symptomatic stenosis with a self-expanding Evolut Pro (Medtronic) 29-mm valve. The procedure was complicated by embolization to the arch. additional deployed, but residual paravalvular leak noted. Because of continued heart failure symptoms, patient presented our institution definitive treatment. Multimodal ...

OBJECTIVES This study introduces a newly designed transcatheter aortic valve system, the J-Valve system, and evaluates its application in patients with predominant aortic regurgitation without significant valve calcification. We also report the early results of one of the first series of transapical implantations of this device and aim to offer guidance on the technical aspects of the procedure...

Paravalvular leak (PVL) after prosthetic valve implantation is a significant complication and it usually occurs early in the postoperative period. We report a case of multiple PVL 17 years after the second mitral valve replacement without evidence of infection. The valve sutures were neither cut nor loosened. None of the sewing cuff of the mitral valve was covered with fibrous tissue. The sewin...

OBJECTIVE We aimed to in-vitro test Amplatzer devices (Amplatzer Vascular Plug II and Amplatzer Vascular Plug III, SJM, St. Paul, MN) in closing PVL generated by transcatheter balloon expandable aortic valve prosthesis in order to quantify the effective treatment of PVL. BACKGROUND Transcatheter aortic valve implantation (TAVI) procedures represent the treatment of choice for high risk patien...

Background Imaging of the aortic annulus is paramount for the success of transcatheter aortic valve implantation (TAVI) to obviate prosthesis size mismatch. The aortic annulus is a dynamic structure with alterations of its ellipsoid shape during the cardiac cycle. The objective of this study was to investigate with cine-MRI the changes of the sagittal and coronal diameter of the aortic annulus ...

Intraoperative transesophageal echocardiography is now used routinely during aortic valve replacement, allowing immediate evaluation of replaced or repaired valves. It is well recognised that high transvalvular pressure gradients can be detected immediately after implantation of a prosthetic aortic valve which may be due to multifactorial confounding variables, including functional phenomena, p...

UNLABELLED A 74-year-old woman who was diagnosed with right breast cancer at age 39 had been treated with mastectomy, and repeated cycles of chemotherapy and radiotherapy. She also had a history of coronary artery disease, wherein two coronary artery bypass grafts were performed 3 years ago. At that time, porcelain aorta was detected during surgery. In the year prior to admission, the patient p...

BACKGROUND The design of a percutaneous implantable prosthetic heart valve has become an important area for investigation. A percutaneously implanted heart valve (PHV) composed of 3 bovine pericardial leaflets mounted within a balloon-expandable stent was developed. After ex vivo testing and animal implantation studies, the first human implantation was performed in a 57-year-old man with calcif...